Skip to content
Explore cutting-edge technology insights, innovation trends…

Zimbabwe Turns Down ‘Unbalanced’ American Healthcare Assistance Agreement Over Information Apprehensions

Health aid illustration
The offered American funding was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) over five years because of Washington's insistence on sensitive biological samples.

The decision came to light following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".

A government representative later clarified that the United States was demanding access to biological samples for scientific study and commercial gain but refused to guarantee the benefits from future treatments.

"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged continued talks to reach a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.

Broader Background

This development follows a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement after legal challenges were raised about the safety of citizens' health data.

After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had managed assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and accountability.

As per reports, 16 nations in Africa have to date signed these new health pacts, representing more than $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported initiatives," Tremont said.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to provide its genetic material and health information over an extended period, without any corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could result from that provided information," he stated.

"In essence, our country would provide the basic resources for medical research with no assurance that the final treatments would be accessible to our citizens if a new health crisis emerge."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining structures already established via the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with future pandemics.

"This system is intended to guarantee that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."

Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.

"We encourage ongoing dialogue with our American counterparts on how future co-operation could be designed in a manner that honours the independence and interests of both nations."

Medical Community Response

Medical experts said it acknowledged the official position, but recommended that talks need to persist given that a large portion of the country's HIV programmes relied on foreign aid.

"In cases where specific concerns arise, such as those involving information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group commented.

This impasse highlights the ongoing challenges between receiving crucial foreign assistance and protecting local interests in an increasingly data-driven world.

The writer

Michael Butler

A tech journalist and software developer with over a decade of experience covering AI, cybersecurity, and emerging technologies.

TechPulse Blog

Type to search articles.